Edgewise Therapeutics Inc
(EWTX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2020 | 06-2020 | 03-2020 | |
| Cash Flows From Operating Activities | |||
| Net Income | -10,781 | -7,139 | -3,185 |
| Depreciation Amortization | 135 | 85 | 40 |
| Accounts payable and accrued liabilities | 384 | 179 | 458 |
| Other Working Capital | 486 | 236 | 361 |
| Other Operating Activity | -220 | -85 | -413 |
| Operating Cash Flow | $-9,996 | $-6,724 | $-2,739 |
| Cash Flows From Investing Activities | |||
| PPE Investments | -203 | -197 | -9 |
| Investing Cash Flow | $-203 | $-197 | $-9 |
| Cash Flows From Financing Activities | |||
| Common Stock Issued | 202 | 135 | N/A |
| Other Financing Activity | 25,075 | 0 | 0 |
| Financing Cash Flow | $25,277 | $135 | $N/A |
| Beginning Cash Position | 23,653 | 23,653 | 23,653 |
| End Cash Position | 38,731 | 16,867 | 20,905 |
| Net Cash Flow | $15,078 | $-6,786 | $-2,748 |
| Free Cash Flow | |||
| Operating Cash Flow | -9,996 | -6,724 | -2,739 |
| Capital Expenditure | -203 | -197 | -9 |
| Free Cash Flow | -10,199 | -6,921 | -2,748 |